PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-36.93
Negative P/E while Healthcare median is -2.77. Seth Klarman would scrutinize path to profitability versus peers.
36.62
P/S exceeding 1.5x Healthcare median of 12.24. Jim Chanos would check for potential multiple compression risks.
1.42
P/B 50-90% of Healthcare median of 2.73. Mohnish Pabrai would examine if this discount presents opportunity.
-56.16
Negative FCF while Healthcare median P/FCF is -14.24. Seth Klarman would investigate cash flow improvement potential.
-65.99
Negative operating cash flow while Healthcare median P/OCF is -11.92. Seth Klarman would investigate operational improvement potential.
1.42
Fair value ratio 50-90% of Healthcare median of 2.74. Mohnish Pabrai would examine if this gap presents opportunity.
-0.68%
Negative earnings while Healthcare median yield is -1.42%. Seth Klarman would investigate path to profitability.
-1.78%
Negative FCF while Healthcare median yield is -1.37%. Seth Klarman would investigate cash flow improvement potential.